作者: Nicoletta Ronda , Vincent Hurez , Michel D. Kazatchkine
DOI: 10.1111/J.1423-0410.1993.TB02521.X
关键词:
摘要: The proven beneficial effect of intravenous immunoglobulins (IVIg) in certain autoimmune disorders has led to the development clinical trials other and systemic inflammatory diseases. In parallel, experimental studies are being carried out better understand mechanisms action IVIg. this review, we discuss use IVIg possible by which may be effective various A understanding disease will allow optimization their as a therapeutic alternative conventional immunosuppression.